General Information
Revision date
2021-08-26
Product name
KEPPRA TABLETS
Product Synonyms
KEPPRA 250 MG TABLETS * KEPPRA 500 MG TABLETS * KEPPRA 750 MG TABLETS *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, oral Category 4 H302 - Harmful if swallowed. Hazard summary Harmful if swallowed. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
AMORPHOUS SYNTHETIC SILICA GEL, CROSCARMELLOSE SODIUM, LEVETIRACETAM, OPADRY WHITE
Signal word
Warning
Hazard statements
H302 Harmful if swallowed.
Prevention
P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P330 Rinse mouth.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
96.06 % of the mixture consists of component(s) of unknown acute dermal toxicity. 5.75 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 5.75 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
